FDA Orange Book
Is there a generic for Cimduo?
Cimduo contains lamivudine and tenofovir disoproxil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Cimduo (lamivudine and tenofovir disoproxil).
Run it in Rivvi
Map Cimduo and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Cimduo products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 300MG;300MG | Marketed (Rx) | None | 0 | None |
NDA 022141, held by MYLAN LABORATORIES LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Cimduo NDC codes
Questions
Is there a generic for Cimduo?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Cimduo (lamivudine and tenofovir disoproxil).
What is the generic name for Cimduo?
The active ingredient in Cimduo is lamivudine and tenofovir disoproxil, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Cimduo and Lamivudine and Tenofovir Disoproxil
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitors listFDA drug class
- NDC 49502-450Cimduo NDC record
- Controlled substances by scheduleDEA list
- Generic drug lookupFDA Orange Book
- Drug classesFDA EPC